Publikationen von Mira Dalal
Alle Typen
Zeitschriftenartikel (17)
2014
Zeitschriftenartikel
152 (1), S. 255 - 260 (2014)
Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature. SCHIZOPHRENIA RESEARCH 2012
Zeitschriftenartikel
135 (1-3), S. 123 - 127 (2012)
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research
Zeitschriftenartikel
35 (2), S. 231 - 236 (2012)
Glucose Tolerance in Patients with Narcolepsy. Sleep 2009
Zeitschriftenartikel
34 (1), S. 118 - 128 (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 2008
Zeitschriftenartikel
17 (Suppl. 1), S. 201 - 201 (2008)
What does paroxetine do with sleep? Its effects in mdr 1a/1b (-/-) and fvb wild-type mice. Journal of Sleep Research 2007
Zeitschriftenartikel
27 (6), S. 662 - 666 (2007)
Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology
Zeitschriftenartikel
40 (5), S. 241 - 241 (2007)
Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry
Zeitschriftenartikel
34 (2), S. 93 - 94 (2007)
Gabapentin bei einer Patientin mit Panikstörung und Unverträglichkeit von Carbamazepin während des Benzodiazepinentzugs. Psychiatrische Praxis
Zeitschriftenartikel
2, S. 293 - 302 (2007)
Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 2006
Zeitschriftenartikel
114, S. 322 - 328 (2006)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 2005
Zeitschriftenartikel
38 (5), S. 230 - 230 (2005)
Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 2004
Zeitschriftenartikel
286 (6), S. E963 - E967 (2004)
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. American Journal of Physiology-Endocrinology and Metabolism 2003
Zeitschriftenartikel
36 (5), S. 218 - 218 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry
Zeitschriftenartikel
36 (5), S. 263 - 264 (2003)
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects - First results from a double-blind, placebocontrolled study. Pharmacopsychiatry
Zeitschriftenartikel
8, S. 836 - 837 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Molecular Psychiatry 2002
Zeitschriftenartikel
11 (3), S. 273 - 273 (2002)
Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy. Journal of Sleep Research 2001
Zeitschriftenartikel
56, S. 1749 - 1751 (2001)
Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology Buchkapitel (1)
2001
Buchkapitel
Leptin and psychopharmacology. In: Psychoneuroimmunology. Hypotheses and Current Research. Advances in Biological Psychiatry, Vol. 20, S. 20 - 29 (Hg. Sperner-Unterweger, B.; Fleischhacker, W.; Kaschka, W.). Karger, Basel (2001)